| UNITED      STATESSECURITIES      AND EXCHANGE COMMISSIONWashington,      D.C.  20549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  FORM      10-Q                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| þ QUARTERLY REPORT PURSUANT      TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|  For      the quarterly period ended January 31, 2010 OR  TRANSITION REPORT      PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF      1934 For      the transition period from ___________ to ___________ Commission      File Number 1-5865                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Gerber      Scientific, Inc.(Exact      name of registrant as specified in its charter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Connecticut                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 06-0640743 |
| (State      or other jurisdiction of incorporation or organization)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | (I.R.S.      Employer Identification No.) |
| 83      Gerber Road West, South Windsor, Connecticut(Address      of principal executive offices)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 06074(Zip      Code) |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Registrant's      telephone number, including area code:  (860)      644-1551                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Indicate      by check mark whether the registrant (1) has filed all reports required to      be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934      during the preceding 12 months (or for such shorter period that the      registrant was required to file such reports), and (2) has been subject to      such filing requirements for the past 90 days.  Yes þ    No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|  Indicate      by check mark whether the registrant has submitted electronically and      posted on its corporate Web site, if any, every Interactive Data File      required to be submitted and posted pursuant to Rule 405 of Regulation S-T      (§232.405 of this chapter) during the preceding 12 months (or for such      shorter period that the registrant was required to submit and post such      files).  Yes    No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Indicate      by check mark whether the registrant is a large accelerated filer, an      accelerated filer, a non-accelerated filer, or a smaller reporting      company.  See the definitions of “large accelerated filer,”      “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the      Exchange Act.Large      accelerated filer                                                                                     Accelerated      filer þ                               Non-accelerated      filer  (Do not check if a smaller reporting      company)       Smaller reporting      company     |
| Indicate      by check mark whether the registrant is a shell company (as defined in      Rule 12b-2 of the Exchange Act).Yes          No þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 25,157,590      shares of common stock of the registrant were outstanding as of February      28, 2010, exclusive of treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |   |   |

----

|          | GERBER      SCIENTIFIC, INC.Index      to Quarterly Reporton      Form 10-QFiscal      Quarter Ended January 31, 2010 |   |   |   |
|---------------|-----------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
| PART I        |                                                                                                                  | PAGE   |   |
|          |                                                                                                                  |   |   |   |
| Item 1.       | Financial Statements                                                                                                  |   |   |   |
|          | Condensed Consolidated Statements of      Operations                                                                  |   |   | 3-4    |   |
|          | Condensed Consolidated Balance      Sheets                                                                            |   |   | 5      |   |
|          | Condensed Consolidated Statements of Cash      Flows                                                                  |   |   | 6      |   |
|          | Notes to Condensed Consolidated Financial      Statements                                                             |   |   | 7-18   |   |
| Item 2        | Management's Discussion and Analysis of Financial Condition      and Results of Operations                            |   |   | 19-31  |   |
| Item 3.       | Quantitative and Qualitative Disclosures about Market      Risk                                                       |   |   | 31     |   |
| Item 4.       | Controls and Procedures                                                                                               |   |   | 31     |   |
|          |                                                                                                                  |   |   |   |   |
| PART II       |                                                                                                                  |   |   |   |
|          |                                                                                                                  |   |   |   |   |
| Item 1A.      | Risk Factors                                                                                                          |   |   | 32     |   |
| Item 2.       | Unregistered Sales of Equity      Securities and Use of Proceeds                                                      |   |   | 32     |   |
| Item 6.       | Exhibits                                                                                                              |   |   | 33     |   |
|          |                                                                                                                  |   |   |   |   |
| Signature     |                                                                                                                  |   | 34     |   |
| Exhibit Index |                                                                                                                  |   | 35     |   |

----

PART I – FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Condensed Consolidated Statements ofOperations

|                                                                                    | For      the Fiscal Quarters Ended January 31, |   |
|-----------------------------------------------------------------------------------------|------------------------------------------------|--------|
| In      thousands, except per share data                                                |                                           | 2010   |   |   | 2009 |   |
| Revenue:                                                                                |                                           |   |   |   |   |   |
|      Product      sales                                        |                                           | $      | 94,794 |   |   | $ | 88,752 |   |
|      Service      sales                                        |                                           |   | 15,877 |   |   |   | 17,439 |   |
|                                                                                    |                                           |   | 110,671 |   |   |   | 106,191 |   |
| Cost      of Sales:                                                                     |                                           |   |   |   |   |   |   |   |
|      Cost      of products sold                                |                                           |   | 67,618 |   |   |   | 63,674 |   |
|      Cost      of services sold                                |                                           |   | 10,196 |   |   |   | 10,291 |   |
|                                                                                    |                                           |   | 77,814 |   |   |   | 73,965 |   |
|                                                                                    |                                           |   |   |   |   |   |   |   |
| Gross      profit                                                                       |                                           |   | 32,857 |   |   |   | 32,226 |   |
|                                                                                    |                                           |   |   |   |   |   |   |   |
| Selling,      general and administrative expenses                                       |                                           |   | 27,276 |   |   |   | 27,122 |   |
| Research      and development                                                           |                                           |   | 4,626 |   |   |   | 4,847 |   |
| Restructuring      and other expenses                                                   |                                           |   | 1,194 |   |   |   | 40 |   |
| Operating      (loss) income                                                            |                                           |   | (239 | ) |   |   | 217 |   |
|                                                                                    |                                           |   |   |   |   |   |   |   |
| Other      income (expense), net                                                        |                                           |   | (126 | ) |   |   | (2,470 | ) |
| Interest      expense                                                                   |                                           |   | (1,374 | ) |   |   | (654 | ) |
| Loss      from continuing operations before income taxes                                |                                           |   | (1,739 | ) |   |   | (2,907 | ) |
| Income      tax benefit                                                                 |                                           |   | (981 | ) |   |   | (1,616 | ) |
| Loss      from continuing operations, net of taxes                                      |                                           |   | (758 | ) |   |   | (1,291 | ) |
| Loss      from discontinued operations, net of taxes of $5 and $(25),      respectively | (51                                            | )      |   |   | (941 | ) |
| Net      loss                                                                           |                                           | $      | (809 | ) |   | $ | (2,232 | ) |
|                                                                                    |                                           |   |   |   |   |   |   |   |
| Basic      loss per common share:                                                       |                                           |   |   |   |   |   |   |   |
|   Continuing      operations                                                  |                                           | $      | (0.03 | ) |   | $ | (0.05 | ) |
|   Discontinued      operations                                                |                                           |   | --- |   |   |   | (0.04 | ) |
| Basic      loss per common share                                                        |                                           | $      | (0.03 | ) |   | $ | (0.09 | ) |
| Diluted      loss per common share:                                                     |                                           |   |   |   |   |   |   |   |
|   Continuing      operations                                                  |                                           | $      | (0.03 | ) |   | $ | (0.05 | ) |
|   Discontinued      operations                                                |                                           |   | --- |   |   |   | (0.04 | ) |
| Diluted      loss per common share                                                      |                                           | $      | (0.03 | ) |   | $ | (0.09 | ) |
|                                                                                    |                                           |   |   |   |   |   |   |   |
| Weighted      Average Common Shares Outstanding:                                        |                                           |   |   |   |   |   |   |   |
|   Basic                                                                       |                                           |   | 25,195 |   |   |   | 24,131 |   |
|   Diluted                                                                     |                                           |   | 25,195 |   |   |   | 24,131 |   |

----

|                                                                                     | For      the Nine Months Ended January 31, |   |
|------------------------------------------------------------------------------------------|--------------------------------------------|--------|
| In      thousands, except per share data                                                 |                                       | 2010   |   |   | 2009 |   |
| Revenue:                                                                                 |                                       |   |   |   |   |   |
|      Product      sales                                         |                                       | $      | 292,104 |   |   | $ | 341,702 |   |
|      Service      sales                                         |                                       |   | 49,315 |   |   |   | 55,207 |   |
|                                                                                     |                                       |   | 341,419 |   |   |   | 396,909 |   |
| Cost      of Sales:                                                                      |                                       |   |   |   |   |   |   |   |
|      Cost      of products sold                                 |                                       |   | 211,048 |   |   |   | 247,298 |   |
|      Cost      of services sold                                 |                                       |   | 30,267 |   |   |   | 35,636 |   |
|                                                                                     |                                       |   | 241,315 |   |   |   | 282,934 |   |
|                                                                                     |                                       |   |   |   |   |   |   |   |
| Gross      profit                                                                        |                                       |   | 100,104 |   |   |   | 113,975 |   |
|                                                                                     |                                       |   |   |   |   |   |   |   |
| Selling,      general and administrative expenses                                        |                                       |   | 78,987 |   |   |   | 88,996 |   |
| Research      and development                                                            |                                       |   | 13,586 |   |   |   | 16,778 |   |
| Restructuring      and other expenses                                                    |                                       |   | 1,450 |   |   |   | 884 |   |
| Operating      income                                                                    |                                       |   | 6,081 |   |   |   | 7,317 |   |
|                                                                                     |                                       |   |   |   |   |   |   |   |
| Other      income (expense), net                                                         |                                       |   | (1,525 | ) |   |   | (3,007 | ) |
| Interest      expense                                                                    |                                       |   | (3,234 | ) |   |   | (1,941 | ) |
| Income      from continuing operations before income taxes                               |                                       |   | 1,322 |   |   |   | 2,369 |   |
| Income      tax benefit                                                                  |                                       |   | (996 | ) |   |   | (3,429 | ) |
| Income      from continuing operations, net of taxes                                     |                                       |   | 2,318 |   |   |   | 5,798 |   |
| Loss      from discontinued operations, net of taxes of ($886) and $5,      respectively | (2,154                                     | )      |   |   | (1,255 | ) |
| Net      income                                                                          |                                       | $      | 164 |   |   | $ | 4,543 |   |
|                                                                                     |                                       |   |   |   |   |   |   |   |
| Basic      earnings (loss) per common share:                                             |                                       |   |   |   |   |   |   |   |
|   Continuing      operations                                                   |                                       | $      | 0.09 |   |   | $ | 0.24 |   |
|   Discontinued      operations                                                 |                                       |   | (0.08 | ) |   |   | (0.05 | ) |
| Basic      earnings per common share                                                     |                                       | $      | 0.01 |   |   | $ | 0.19 |   |
| Diluted      earnings (loss) per common share:                                           |                                       |   |   |   |   |   |   |   |
|   Continuing      operations                                                   |                                       | $      | 0.09 |   |   | $ | 0.24 |   |
|   Discontinued      operations                                                 |                                       |   | (0.08 | ) |   |   | (0.05 | ) |
| Diluted      earnings per common share                                                   |                                       | $      | 0.01 |   |   | $ | 0.19 |   |
|                                                                                     |                                       |   |   |   |   |   |   |   |
| Weighted      Average Common Shares Outstanding:                                         |                                       |   |   |   |   |   |   |   |
|   Basic                                                                        |                                       |   | 24,904 |   |   |   | 23,953 |   |
|   Diluted                                                                      |                                       |   | 24,936 |   |   |   | 24,064 |   |

----

Condensed Consolidated Balance Sheets

|                                                                            |   | January      31, |    |   | April      30, |   |
|---------------------------------------------------------------------------------|--------|------------------|---------|--------|----------------|--------|
| In      thousands                                                               |   | 2010             |    |   | 2009           |   |
| Assets:                                                                         |   |             |    |   |           |   |
| Current      Assets:                                                            |   |             |    |   |           |   |
|      Cash      and cash equivalents                    |   | $                | 7,921   |   |           | $      | 10,313 |   |
|      Accounts      receivable, net                     |   |             | 72,744  |   |           |   | 87,798 |   |
|      Inventories                                       |   |             | 66,883  |   |           |   | 72,108 |   |
|      Deferred      tax assets, net                     |   |             | 9,702   |   |           |   | 9,022 |   |
|      Prepaid      expenses and other current assets    |   |             | 5,717   |   |           |   | 4,659 |   |
|         Total      Current Assets       |   |             | 162,967 |   |           |   | 183,900 |   |
| Property,      plant and equipment, net                                         |   |             | 33,423  |   |           |   | 37,119 |   |
| Goodwill                                                                        |   |             | 83,027  |   |           |   | 76,940 |   |
| Deferred      tax assets, net                                                   |   |             | 45,640  |   |           |   | 43,339 |   |
| Other      assets                                                               |   |             | 21,416  |   |           |   | 17,919 |   |
|         Total      Assets               |   | $                | 346,473 |   |           | $      | 359,217 |   |
| Liabilities      and Shareholders' Equity:                                      |   |             |    |   |           |   |   |   |
| Current      Liabilities:                                                       |   |             |    |   |           |   |   |   |
|      Accounts      payable                             |   | $                | 38,566  |   |           | $      | 37,494 |   |
|      Accrued      compensation and benefits            |   |             | 12,717  |   |           |   | 15,735 |   |
|      Other      accrued liabilities                    |   |             | 22,088  |   |           |   | 24,748 |   |
|      Deferred      revenue                             |   |             | 12,329  |   |           |   | 13,084 |   |
|         Total      Current Liabilities  |   |             | 85,700  |   |           |   | 91,061 |   |
| Long-term      debt                                                             |   |             | 45,000  |   |           |   | 73,500 |   |
| Accrued      pension benefit liability                                          |   |             | 30,366  |   |           |   | 29,629 |   |
| Other      long-term liabilities                                                |   |             | 21,765  |   |           |   | 16,725 |   |
|                                                                            |   |             |    |   |           |   |   |   |
| Commitments      and contingencies                                              |   |             |    |   |           |   |   |   |
|  Shareholders'      Equity:                                                |   |             |    |   |           |   |   |   |
|      Preferred      stock                              |   |             | ---     |   |           |   | --- |   |
|      Common      stock                                 |   |             | 257     |   |           |   | 252 |   |
|      Paid-in      capital                              |   |             | 81,531  |   |           |   | 79,198 |   |
|      Retained      earnings                            |   |             | 97,826  |   |           |   | 97,662 |   |
|      Treasury      stock                               |   |             | (11,035 | )      |           |   | (11,531 | ) |
|      Accumulated      other comprehensive loss         |   |             | (4,937  | )      |           |   | (17,279 | )  |
|         Total      Shareholders' Equity |   |             | 163,642 |   |           |   | 148,302 |   |
| Total      Liabilities and Shareholders' Equity                                 |   | $                | 346,473 |   |           | $      | 359,217 |   |

----

Condensed Consolidated Statements of CashFlows

|                                                                                                                        | For      the Nine Months Ended January 31, |   |
|-----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|--------|
| In      thousands                                                                                                           |                                       | 2010   |   |   | 2009 |   |
| Cash      flows from operating activities:                                                                                  |                                       |   |   |   |   |   |
|  Net      income                                                                                                       |                                       | $      | 164 |   |   | $ | 4,543 |   |
| Adjustments      to reconcile net income to cash provided byoperating activities:                                      |                                       |   |   |   |   |   |   |   |
|        Depreciation      and amortization                                                |                                       |   | 7,250 |   |   |   | 7,547 |   |
|        Deferred      income taxes                                                        |                                       |   | (2,430 | ) |   |   | (5,173 | ) |
|        Stock-based      compensation                                                     |                                       |   | 2,914 |   |   |   | 2,428 |   |
|        Loss      (gain) on sale of assets                                                |                                       |   | 2,328 |   |   |   | (622 | ) |
|        Other-than-temporary      impairment charge                                       |                                       |   | --- |   |   |   | 2,290 |   |
|        Other      noncash items                                                          |                                       |   | 1,525 |   |   |   | 977 |   |
|        Changes      in operating accounts, excluding effects of acquisitions:            |                                       |   |   |   |   |   |   |   |
|             Accounts      receivable                            |                                       |   | 13,785 |   |   |   | 27,929 |   |
|             Inventories                                         |                                       |   | (233 | ) |   |   | (3,166 | ) |
|             Prepaid      expenses and other assets              |                                       |   | (775 | ) |   |   | (114 | ) |
|             Accounts      payable and other accrued liabilities |                                       |   | (1,717 | ) |   |   | (21,577 | ) |
|             Accrued      compensation and benefits              |                                       |   | (3,333 | ) |   |   | (8,744 | ) |
| Net      cash provided by operating activities                                                                              |                                       |   | 19,478 |   |   |   | 6,318 |   |
| Cash      flows from investing activities:                                                                                  |                                       |   |   |   |   |   |   |   |
|    Capital      expenditures                                                                                 |                                       |   | (3,231 | ) |   |   | (6,471 | ) |
|    Proceeds      from sale of net assets                                                                     |                                       |   | 13,116 |   |   |   | 2,590 |   |
|    Proceeds      from sale of available for sale investments                                                 |                                       |   | 149 |   |   |   | 705 |   |
|    Purchases      of available for sale investments                                                          |                                       |   | (113 | ) |   |   | (432 | ) |
|    Business      acquisitions                                                                                |                                       |   | (3,473 | ) |   |   | (34,273 | ) |
|    Investments      in intangible assets                                                                     |                                       |   | (1,149 | ) |   |   | (678 | ) |
| Net      cash provided by (used for) investing activities                                                                   |                                       |   | 5,299 |   |   |   | (38,559 | ) |
| Cash      flows from financing activities:                                                                                  |                                       |   |   |   |   |   |   |   |
|    Debt      repayments                                                                                      |                                       |   | (88,676 | ) |   |   | (56,771 | ) |
|    Debt      proceeds                                                                                        |                                       |   | 61,104 |   |   |   | 88,500 |   |
|    Debt      issuance costs                                                                                  |                                       |   | (494 | ) |   |   | --- |   |
|    Common      stock activity                                                                                |                                       |   | (190 | ) |   |   | 899 |   |
| Net      cash (used for) provided by financing activities                                                                   |                                       |   | (28,256 | ) |   |   | 32,628 |   |
| Effect      of exchange rate changes on cash                                                                                |                                       |   | 1,087 |   |   |   | (3,339 | ) |
| Decrease      in cash and cash equivalents                                                                                  |                                       |   | (2,392 | ) |   |   | (2,952 | ) |
| Cash      and cash equivalents at beginning of period                                                                       |                                       |   | 10,313 |   |   |   | 13,892 |   |
| Cash      and cash equivalents at end of period                                                                             |                                       | $      | 7,921 |   |   | $ | 10,940 |   |

----

Notes to Condensed Consolidated Financial Statements

----

|                                                                   |   | January      31, |   |   | April      30, |   |
|------------------------------------------------------------------------|--------|------------------|--------|--------|----------------|--------|
| In      thousands                                                      |   | 2010             |   |   | 2009           |   |
| Raw      materials and purchased parts                                 |   | $                | 55,657 |   |           | $      | 58,779 |   |
| Work      in process                                                   |   |             | 1,836  |   |           |   | 3,510 |   |
| Finished      goods                                                    |   |             | 9,390  |   |           |   | 9,819 |   |
|         Total      inventories |   | $                | 66,883 |   |           | $      | 72,108 |   |

|  In      thousands                                           |   | November      25, 2009 |   |
|-------------------------------------------------------------------|--------|------------------------|--------|
| Assets      acquired:                                             |   |                   |   |
| Accounts      receivable                                          |   | $                      | 208    |   |
| Prepaid      and other assets                                     |   |                   | 12     |   |
| Goodwill                                                          |   |                   | 3,531  |   |
| Other      assets                                                 |   |                   | 2,797  |   |
|      Total      assets acquired          |   | $                      | 6,548  |   |
| Liabilities      assumed:                                         |   |                   |   |   |
| Accounts      payable                                             |   |                   | 34     |   |
| Other      accrued liabilities                                    |   |                   | 158    |   |
| Deferred      revenue                                             |   |                   | 149    |   |
| Other      long-term liabilities                                  |   |                   | 1,021  |   |
|      Total      liabilities assumed      |   | $                      | 1,362  |   |
| Net      assets acquired                                          |   | $                      | 5,186  |   |
| Consideration:                                                    |   |                   |   |   |
|   Cash      payment                                     |   | $                      | 2,012  |   |
|   Estimated      fair value of contingent consideration |   |                   | 3,174  |   |
| Total      consideration                                          |   | $                      | 5,186  |   |

----

|                                                                                   |   | January      31, 2010 |   |   | April      30, 2009     |   |
|----------------------------------------------------------------------------------------|--------|-----------------------|--------|--------|-------------------------|--------|
|   In      thousands                                                          |   | GrossCarryingAmount   |   |   | AccumulatedAmortization |   |   | GrossCarryingAmount |   |   | AccumulatedAmortization |   |
| Amortized      intangible assets:                                                      |   |                  |   |   |                    |   |   |   |   |   |   |   |
|    Patents                                                              |   | $                     | 8,337  |   |                    | $      | 3,607 |   |   | $ | 7,603 |   |   | $ | 3,210 |   |
|    Other                                                                |   |                  | 8,067  |   |                    |   | 1,080 |   |   |   | 5,131 |   |   |   | 739 |   |
|         Total      amortized intangible assets |   | $                     | 16,404 |   |                    | $      | 4,687 |   |   | $ | 12,734 |   |   | $ | 3,949 |   |

|   In      thousands        |   | Sign      Making and      Specialty Graphics |    |    | Apparel      andFlexibleMaterials |   |   | OphthalmicLensProcessing |   |   | Total   |    |
|--------------------------------------|--------|--------------------------------------------------------|---------|---------|-----------------------------------|--------|--------|--------------------------|--------|--------|---------|---------|
| Balance      as of April 30, 2009:   |   |                                                   |    |    |                              |   |   |                     |   |   |    |    |   |   |   |   |
| Goodwill                             |   | $                                                      | 118,690 |    |                              | $      | 34,207 |                     |   | $      | 38,696  |    |   | $ | 191,593 |   |
| Accumulated      impairment losses   |   |                                                   | (92,953 | )  |                              |   | ---    |                     |   |   | (21,700 | )  |   |   | (114,653 | )  |
| Balance      as of April 30, 2009    |   |                                                   | 25,737  |    |                              |   | 34,207 |                     |   |   | 16,996  |    |   |   | 76,940 |   |
| Business      acquisitions           |   |                                                   | 1,086   |    |                              |   | 3,897  |                     |   |   | ---     |    |   |   | 4,983 |   |
| Business      dispositions           |   |                                                   | (972    | )       |                              |   | (1,581 | )                        |   |   | ---     |    |   |   | (2,553 | ) |
| Effects      of currency translation |   |                                                   | 1,615   |    |                              |   | 2,042  |                     |   |   | --      |    |   |   | 3,657 |   |
| Balance      as of January 31, 2010  |   | $                                                      | 27,466  |    |                              | $      | 38,565 |                     |   | $      | 16,996  |    |   | $ | 83,027 |   |

----

|                                                                                                  |   | For      the Fiscal QuartersEnded      January 31, |    |   | For      the Nine MonthsEnded      January 31, |   |
|-------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------|---------|--------|------------------------------------------------|--------|
|  In      thousands                                                                               |   | 2010                                               |    |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Sign      Making and Specialty Graphics:                                                              |   |                                               |    |   |                                           |   |   |   |   |   |   |   |
|   Gerber      Scientific Products                                                           |   | $                                                  | 9,341   |   |                                           | $      | 11,938 |   |   | $ | 33,603 |   |   | $ | 45,457 |   |
|   Spandex                                                                                   |   |                                               | 50,267  |   |                                           |   | 45,430 |   |   |   | 159,094 |   |   |   | 177,122 |   |
| Sign      Making and Specialty Graphics                                                               |   |                                               | 59,608  |   |                                           |   | 57,368 |   |   |   | 192,697 |   |   |   | 222,579 |   |
| Apparel      and Flexible Materials                                                                   |   |                                               | 40,095  |   |                                           |   | 36,437 |   |   |   | 112,249 |   |   |   | 130,768 |   |
| Ophthalmic      Lens Processing                                                                       |   |                                               | 10,968  |   |                                           |   | 12,386 |   |   |   | 36,473 |   |   |   | 43,562 |   |
|           Consolidated      revenue                 |   | $                                                  | 110,671 |   |                                           | $      | 106,191 |   |   | $  | 341,419 |   |   | $  | 396,909 |   |
|                                                                                                  |   |                                               |    |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
| Sign      Making and Specialty Graphics:                                                              |   |                                               |    |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|   Gerber      Scientific Products                                                           |   | $                                                  | (2,488  | )      |                                           | $      | 334 |   |   | $ | (4,950 | ) |   | $ | (881 | ) |
|   Spandex                                                                                   |   |                                               | 2,730   |   |                                           |   | 704 |   |   |   | 9,255 |   |   |   | 6,832 |   |
| Sign      Making and Specialty Graphics                                                               |   |                                               | 242     |   |                                           |   | 1,038 |   |   |   | 4,305 |   |   |   | 5,951 |   |
| Apparel      and Flexible Materials                                                                   |   |                                               | 4,140   |   |                                           |   | 2,778 |   |   |   | 11,597 |   |   |   | 11,373 |   |
| Ophthalmic      Lens Processing                                                                       |   |                                               | (318    | )      |                                           |   | 737 |   |   |   | 2,002 |   |   |   | 2,625 |   |
|         Segment      operating income                         |   |                                               | 4,064   |   |                                           |   | 4,553 |   |   |   | 17,904 |   |   |   | 19,949 |   |
| Corporate      operating expenses                                                                     |   |                                               | (4,303  | )      |                                           |   | (4,336 | ) |   |   | (11,823 | ) |   |   | (12,632 | ) |
|           Consolidated      operating (loss) income |   | $                                                  | (239    | )      |                                           | $      | 217 |   |   | $ | 6,081 |   |   | $ | 7,317 |   |

----

|                                                                               |   | For      the Fiscal QuartersEnded      January 31, |   |   | For      the Nine MonthsEnded      January 31, |   |
|------------------------------------------------------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
|  In      thousands                                                            |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Net      (loss) income                                                             |   | $                                                  | (809   | )      |                                           | $      | (2,232 | ) |   | $ | 164 |   |   | $ | 4,543 |   |
|                                                                               |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
| Other      comprehensive (loss) income:                                            |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|     Foreign      currency translation adjustments              |   |                                               | (3,765 | )      |                                           |   | (3,677 | ) |   |   | 11,346 |   |   |   | (31,266 | ) |
|     Defined      benefit pension plans activity, net of tax    |   |                                               | 96     |   |                                           |   | 205 |   |   |   | 288 |   |   |   | 614 |   |
|     Unrealized      investment gain income, net of tax         |   |                                               | 79     |   |                                           |   | 1,283 |   |   |   | 450 |   |   |   | 474 |   |
|     Net      gain (loss) on derivative instruments, net of tax |   |                                               | 142    |   |                                           |   | (561 | ) |   |   | 258 |   |   |   | (688 | ) |
| Total      comprehensive (loss) income                                             |   | $                                                  | (4,257 | )      |                                           | $      | (4,982 | ) |   | $  | 12,506 |   |   | $  | (26,323 | ) |

|                                                   |   | For      the Fiscal Quarters Ended January 31, |   |
|--------------------------------------------------------|--------|------------------------------------------------|--------|
|                                                   |   | 2010                                           |   |   | 2009 |   |
|  In      thousands, except per share amounts      |   | NetLoss                                        |   |   | AverageShares |   |   | PerShare |   |   | NetLoss |   |   | AverageShares |   |   | PerShare |   |
| Basic      loss per common share:                      |   |                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing      operations                 |   | $                                              | (758   | ) |   |   | 25,195 |   |   | $ | (0.03 | ) |   | $ | (1,291 | ) |   |   | 24,131 |   |   | $ | (0.05 | ) |
|   Discontinued      operations               |   | $                                              | (51    | ) |   |   | 25,195 |   |   |   | --- |   |   |   | (941 | ) |   |   | 24,131 |   |   |   | (0.04 | ) |
| Basic      loss per common share                       |   | $                                              | (809   | )  |   |   | 25,195 |   |   | $ | (0.03 | ) |   | $ | (2,232 | ) |   |   | 24,131 |   |   | $ | (0.09 | ) |
|                                                   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Dilutedloss per common      share:                     |   |                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing      operations                 |   | $                                              | (758   | ) |   |   | 25,195 |   |   | $ | (0.03 | ) |   | $ | (1,291 | ) |   |   | 24,131 |   |   | $ | (0.05 | ) |
|   Effect      of dilutive options and awards |   |                                           | ---    |   |   |   | --- |   |   |   | --- |   |   |   | --- |   |   |   | --- |   |   |   | --- |   |
|   Continuing      operations                 |   | $                                              | (758   | ) |   |   | 25,195 |   |   | $ | (0.03 | ) |   | $ | (1,291 | ) |   |   | 24,131 |   |   | $ | (0.05 | ) |
|   Discontinued      operations               |   | $                                              | (51    | ) |   |   | 25,195 |   |   |   | --- |   |   |   | (941 | ) |   |   | 24,131 |   |   |   | (0.04 | ) |
| Diluted      loss per common share                     |   | $                                              | (809   | )  |   |   | 25,195 |   |   | $ | (0.03 | ) |   | $ | (2,232 | ) |   |   | 24,131 |   |   | $ | (0.09 | ) |

----

|                                                   |   | For      the Nine Months Ended January 31, |   |
|--------------------------------------------------------|--------|--------------------------------------------|--------|
|                                                   |   | 2010                                       |   |   | 2009 |   |
|  In      thousands, except per share amounts      |   | NetIncome                                  |   |   | AverageShares |   |   | PerShare |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |
| Basic      earnings (loss) per common share:           |   |                                       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing      operations                 |   | $                                          | 2,318  |   |   |   | 24,904 |   |   | $ | 0.09 |   |   | $ | 5,798 |   |   |   | 23,953 |   |   | $ | 0.24 |   |
|   Discontinued      operations               |   | $                                          | (2,154 | ) |   |   | 24,904 |   |   | $ | (0.08 | ) |   |   | (1,255 | ) |   |   | 23,953 |   |   |   | (0.05 | ) |
| Basic      earnings per common share                   |   | $                                          | 164    |   |   |   | 24,904 |   |   | $ | 0.01 |   |   | $ | 4,543 |   |   |   | 23,953 |   |   | $ | 0.19 |   |
|                                                   |   |                                       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Dilutedearnings (loss) per common      share:          |   |                                       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing      operations                 |   | $                                          | 2,318  |   |   |   | 24,904 |   |   | $ | 0.09 |   |   | $ | 5,798 |   |   |   | 23,953 |   |   | $ | 0.24 |   |
|   Effect      of dilutive options and awards |   |                                       | ---    |   |   |   | 32 |   |   |   | --- |   |   |   | --- |   |   |   | 111 |   |   |   | --- |   |
|   Continuing      operations                 |   | $                                          | 2,318  |   |   |   | 24,936 |   |   | $ | 0.09 |   |   | $ | 5,798 |   |   |   | 24,064 |   |   | $ | 0.24 |   |
|   Discontinued      operations               |   | $                                          | (2,154 | ) |   |   | 24,936 |   |   | $ | (0.08 | ) |   |   | (1,255 | ) |   |   | 24,064 |   |   |   | (0.05 | ) |
| Diluted      earnings per common share                 |   | $                                          | 164    |   |   |   | 24,936 |   |   | $ | 0.01 |   |   | $ | 4,543 |   |   |   | 24,064 |   |   | $ | 0.19 |   |

|                                         | For      the Nine Months Ended January 31, |   |
|----------------------------------------------|--------------------------------------------|--------|
| In      thousands                            |                                       | 2010   |   |   | 2009 |   |
| Beginning      balance                       |                                       | $      | 2,815 |   |   | $ | 2,327 |   |
| Warranties      issued in the current period |                                       |   | 4,342 |   |   |   | 3,738 |   |
| Reductions      for costs incurred           |                                       |   | (4,128 | ) |   |   | (3,984 | ) |
| Impact      of business acquisitions         |                                       |   | --- |   |   |   | 668 |   |
| Impact      of business dispositions         |                                       |   | (574 | ) |   |   | --- |   |
| Ending      balance                          |                                       | $      | 2,455 |   |   | $ | 2,749 |   |

|                                      |   | For      the Fiscal QuartersEnded      January 31, |   |   | For      the Nine MonthsEnded      January 31, |   |
|-------------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
|  In      thousands                   |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Service      cost                         |   | $                                                  | ---    |   |                                           | $      | 597 |   |   | $ | --- |   |   | $ | 1,791 |   |
| Interest      cost                        |   |                                               | 1,698  |   |                                           |   | 1,770 |   |   |   | 5,096 |   |   |   | 5,310 |   |
| Expected      return on plan assets       |   |                                               | (1,316 | )      |                                           |   | (1,709 | ) |   |   | (3,948 | ) |   |   | (5,129 | ) |
| Amortization      of:                     |   |                                               |   |   |                                           |   |   |   |   |   |   |   |   |   |   |   |
|    Prior      service cost |   |                                               | ---    |   |                                           |   | 73 |   |   |   | --- |   |   |   | 219 |   |
|    Actuarial      loss     |   |                                               | 153    |   |                                           |   | 253 |   |   |   | 459 |   |   |   | 759 |   |
| Net      periodic benefit cost            |   | $                                                  | 535    |   |                                           | $      | 984 |   |   | $ | 1,607 |   |   | $ | 2,950 |   |

----

|                                                         |                                 |   |                            |
|--------------------------------------------------------------|--------------------------------------|--------|----------------------------|
|  In      thousands                                      |  Balance      Sheet Location    |   | January      31, 2010 |   |   | April      30, 2009 |   |
| Derivatives      designated as hedging instruments:          |                                 |   |                       |   |   |   |   |
|     Interest      rate swap arrangements | Other      accrued liabilities  |   | $                          | 770 |   |   | $ | 1,181 |   |

----

|      In      thousands                                                               |   | For      the Fiscal Quarter Ended January      31, 2010 |   |   | For      the Nine Months Ended      January 31, 2010 |   |
|---------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------|--------|--------|-----------------------------------------------------------|--------|
| Loss      recognized in Accumulated Other Comprehensive Loss before tax      effect                           |   | $                                                                 | 71     |   |                                                      | $      | 404 |   |
| Loss      reclassified from Accumulated Other Comprehensive Loss to Interest Expense      (effective portion) |   | $                                                                 | 297    |   |                                                      | $      | 815 |   |

|   In      thousands                         |   | Total  |   |   | Quotedprices      inactivemarkets(Level      1) |   | Significantotherobservableinputs(Level      2) |   |   | Significantunobservableinputs(Level      3) |   |
|-------------------------------------------------------|--------|--------|--------|--------|-------------------------------------------------|--------|------------------------------------------------|--------|--------|---------------------------------------------|--------|
| Available      for sale investments                   |   | $      | 3,708  |   |                                            | $      | 3,708                                          |   |   | $                                           | ---    |   |   | $ | --- |   |
| Interest      rate swap agreements                    |   |   | (770   | )      |                                            |   | ---                                            |   |   |                                        | (770   | ) |   |   | --- |   |
| Estimated      fair value of contingent consideration |   |   | (3,174 | )      |                                            |   | ---                                            |   |   |                                        | ---    |   |   |   | (3,174 | ) |
|     Total                         |   | $      | (236   | )      |                                            | $      | 3,708                                          |   |   | $                                           | (770   | ) |   | $ | (3,174 | ) |

----

|                                                   |   | For      the Fiscal Quarters EndedJanuary      31, |    |   | For      the Nine Months EndedJanuary      31, |   |
|--------------------------------------------------------|--------|----------------------------------------------------|---------|--------|------------------------------------------------|--------|
| In      thousands                                      |   | 2010                                               |    |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Revenue      from discontinued operations              |   | $                                                  | ---     |   |                                           | $      | 6,572 |   |   | $ | 5,973 |   |   | $ | 7,122 |   |
| Pretax      (loss) income from discontinued operations | $      | (181                                               | )  |   | $                                              | (318   | ) |   | $ | 618 |   |   | $ | (131 | ) |

----

|  In      thousands                                 |   | September      1, 2009 |   |
|---------------------------------------------------------|--------|------------------------|--------|
| Assets:                                                 |   |                   |   |
| Accounts      receivable, net                           |   | $                      | 3,069  |   |
| Inventories                                             |   |                   | 3,848  |   |
| Prepaid      and other assets                           |   |                   | 66     |   |
|      Total current      assets |   |                   | 6,983  |   |
| Property,      plant and equipment, net                 |   |                   | 1,336  |   |
|      Total      assets         |   | $                      | 8,319  |   |
| Liabilities:                                            |   |                   |   |   |
| Accounts      payable                                   |   | $                      | 1,142  |   |
| Accrued      compensation and benefits                  |   |                   | 488    |   |
| Other      accrued liabilities                          |   |                   | 1,577  |   |
| Other      liabilities                                  |   |                   | 229    |   |
|      Total      liabilities    |   | $                      | 3,436  |   |
| Net      assets                                         |   | $                      | 4,883  |   |

|                                                   |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|--------------------------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands                                      |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Revenue      from discontinued operations              |   | $                                                  | ---    |   |                                           | $      | 6,574 |   |   | $ | 13,901 |   |   | $ | 25,272 |   |
| Pretax      income (loss) from discontinued operations |   | $                                                  | 21     |   |                                           | $      | (73 | ) |   | $ | (3,392 | ) |   | $ | 33 |   |

|  In      thousands                                 |   | September      30, 2009 |   |
|---------------------------------------------------------|--------|-------------------------|--------|
| Assets:                                                 |   |                    |   |
| Accounts      receivable, net                           |   | $                       | 4,413  |   |
| Inventories                                             |   |                    | 4,579  |   |
| Prepaid      and other assets                           |   |                    | 174    |   |
|      Total current      assets |   |                    | 9,166  |   |
| Property,      plant and equipment, net                 |   |                    | 720    |   |
| Other      long-term assets                             |   |                    | 60     |   |
|      Total      assets         |   | $                       | 9,946  |   |
| Liabilities:                                            |   |                    |   |   |
| Accounts      payable                                   |   | $                       | 1,332  |   |
| Accrued      compensation and benefits                  |   |                    | 130    |   |
| Other      accrued liabilities                          |   |                    | 146    |   |
|      Total      liabilities    |   | $                       | 1,608  |   |
| Net      assets                                         |   | $                       | 8,338  |   |

----

|                                                   |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary31, |   |
|--------------------------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------|--------|
| In      thousands                                      |   | 2010                                               |   |   | 2009                                     |   |   | 2010 |   |   | 2009 |   |
| Revenue      from discontinued operations              |   | $                                                  | ---    |   |                                     | $      | 760 |   |   | $ | 1,234 |   |   | $ | 3,410 |   |
| Pretax      income (loss) from discontinued operations |   | $                                                  | 114    |   |                                     | $      | (575 | )  |   | $ | (266 | )  |   | $ | (1,152 | ) |

| Twelve      Month Period Ended    | Previous      Covenant | Amended      Covenant |
|-----------------------------------|------------------------|-----------------------|
| January      31, 2010             | Maximum      3.25:1    | Maximum      3.00:1   |
| April      30, 2010               | Maximum      3.25:1    | Maximum      3.00:1   |
| July      31, 2010 and thereafter | Maximum      3.00:1    | Maximum      3.00:1   |

----

| Twelve      Month Period Ended       | Previous      Covenant | Amended      Covenant |
|--------------------------------------|------------------------|-----------------------|
| January      31, 2010                | Minimum      2.25:1    | Minimum      1.50:1   |
| April      30, 2010                  | Minimum      2.75:1    | Minimum      2.25:1   |
| July      31, 2010                   | Minimum      3.00:1    | Minimum      2.50:1   |
| October      31, 2010 and thereafter | Minimum      3.00:1    | Minimum      3.00:1   |

----

ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSISOF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

| ·   | expected      financial condition, future earnings, levels of growth, or other measures      of financial performance, or the future size of market segments or      geographic markets; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | economic      conditions; |
|--------------------|---------------------------|

| ·   | planned      cost reductions; |
|--------------------|-------------------------------|

| ·   | future      cash flows and uses of cash and debt reduction  strategies; |
|--------------------|-------------------------------------------------------------------------|

| ·   | prospective      product developments and business growth opportunities, as well as      competitor product developments; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------|

| ·   | demand      for Gerber's products and services; |
|--------------------|-------------------------------------------------|

| ·   | methods      of and costs associated with potential geographic    expansion; |
|--------------------|------------------------------------------------------------------------------|

| ·   | regulatory      and market developments and the impact of such developments on future      operating results; |
|--------------------|---------------------------------------------------------------------------------------------------------------|

| ·   | potential      impacts from credit market risk; |
|--------------------|-------------------------------------------------|

| ·   | future      effective income tax rates; |
|--------------------|-----------------------------------------|

| ·   | the      outcome of contingencies; |
|--------------------|------------------------------------|

| ·   | the      availability and cost of raw materials;and |
|--------------------|-----------------------------------------------------|

| ·   | pension      plan assumptions and futurecontributions. |
|--------------------|--------------------------------------------------------|

----

|                        |   | For      the Fiscal Quarters EndedJanuary      31, |    |   | For      the Nine Months EndedJanuary      31, |   |
|-----------------------------|--------|----------------------------------------------------|---------|--------|------------------------------------------------|--------|
| In      thousands           |   | 2010                                               |    |   | 2009                                           |   |   | Percent      Change |   |   | 2010 |   |   | 2009 |   |   | Percent      Change |   |
| Equipment      and software |   | $                                                  | 30,523  |   |                                           | $      | 30,501 |   |   |   | 0.1 | % |   | $ | 86,252 |   |   | $ | 115,484 |   |   |   | (25.3 | %) |
| Aftermarket      supplies   |   |                                               | 64,271  |   |                                           |   | 58,251 |   |   |   | 10.3 | % |   |   | 205,852 |   |   |   | 226,218 |   |   |   | (9.0 | %) |
| Service                     |   |                                               | 15,877  |   |                                           |   | 17,439 |   |   |   | (9.0 | %) |   |   | 49,315 |   |   |   | 55,207 |   |   |   | (10.7 | %) |
| Total      revenue          |   | $                                                  | 110,671 |   |                                           | $      | 106,191 |   |   |   | 4.2 | % |   | $ | 341,419 |   |   | $ | 396,909 |   |   |   | (14.0 | %) |

----

----

|  In      thousands                                   |   | January      31,2010 |   |   | April      30,2009 |   |
|-----------------------------------------------------------|--------|----------------------|--------|--------|--------------------|--------|
| Backlog:                                                  |   |                 |   |   |               |   |
|    Sign      Making and Specialty Graphics |   | $                    | 825    |   |               | $      | 1,636 |   |
|    Apparel      and Flexible Materials     |   |                 | 24,526 |   |               |   | 21,800 |   |
|    Ophthalmic      Lens Processing         |   |                 | 662    |   |               |   | 1,200 |   |
|                                                      |   | $                    | 26,013 |   |               | $      | 24,636 |   |

|                     |   | For      the Fiscal Quarters EndedJanuary      31, |   | For      the Nine Months EndedJanuary      31, |    |
|--------------------------|--------|----------------------------------------------------|--------|------------------------------------------------|--------------|
| In      thousands        |   | 2010                                               |   | 2009                                           |         | Percent      Change |   | 2010 |   | 2009 |   | Percent      Change |   |
| Gross      profit        |   | $                                                  | 32,857 |                                           | $            | 32,226 |   | 2.0 | % | $ | 100,104 |   | $ | 113,975 |   | (12.2 | %) |
| Gross      profit margin |   |                                               | 29.7   | %                                              |         | 30.3 | % |   |   |   | 29.3 | % |   | 28.7 | % |   |   |

|                                              |   | For      the Fiscal Quarters EndedJanuary      31, |   | For      the Nine Months EndedJanuary      31, |    |
|---------------------------------------------------|--------|----------------------------------------------------|--------|------------------------------------------------|--------------|
| In      thousands                                 |   | 2010                                               |   | 2009                                           |         | PercentChange |   | 2010 |   | 2009 |   | PercentChange |   |
| Selling,      general and administrative expenses |   | $                                                  | 27,276 |                                           | $            | 27,122 |   | 0.6 | % | $ | 78,987 |   | $ | 88,996 |   | (11.2 | %) |
| Percentage      of revenue                        |   |                                               | 24.6   | %                                              |         | 25.5 | % |   |   |   | 23.1 | % |   | 22.4 | % |   |   |

----

|                          |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |    |
|-------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------------|
| In      thousands             |   | 2010                                               |   |   | 2009                                           |         |   | PercentChange |   |   | 2010 |   |   | 2009 |   |   | PercentChange |   |
| Research      and development |   | $                                                  | 4,626  |   |                                           | $            | 4,847 |   |   |   | (4.6 | %) |   | $ | 13,586 |   |   | $ | 16,778 |   |   |   | (19.0 | %) |
| Percentage      of revenue    |   |                                               | 4.2    | %      |                                           |         | 4.6 | % |   |   |   |   |   |   | 4.0 | % |   |   | 4.2 | % |   |   |   |   |

|                                  |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|---------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands                     |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Restructuring      and other expenses |   | $                                                  | 1,194  |   |                                           | $      | 40 |   |   | $ | 1,450 |   |   | $ | 884 |   |

----

|                             |   | For      the Fiscal Quarters EndedJanuary      31, |   |    | For      the Nine Months EndedJanuary      31, |   |
|----------------------------------|--------|----------------------------------------------------|--------|---------|------------------------------------------------|--------|
| In      thousands                |   | 2010                                               |   |    | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Other      income (expense), net |   | $                                                  | (126   | )  |                                           | $      | (2,470 | )  |   | $ | (1,525 | )  |   | $ | (3,007 | )  |

|                                                |   | For      the Fiscal Quarters EndedJanuary      31, |   | For      the Nine Months EndedJanuary      31, |   |
|-----------------------------------------------------|--------|----------------------------------------------------|--------|------------------------------------------------|--------|
| In      thousands                                   |   | 2010                                               |   |                                           | 2009   |   |   | PercentChange |   |   | 2010 |   |   | 2009 |   |   | PercentChange |   |
| Interest      expense                               |   | $                                                  | 1,374  |                                           |   | $ | 654 |   |   |   | 110.1 | % |   | $ | 3,234 |   |   | $ | 1,941 |   |   |   | 66.6 | % |
| Weighted-average      credit facility interest rate |   |                                               | 8.1    | %                                              |   |   | 4.6 | % |   |   |   |   |   |   | 7.3 | % |   |   | 5.1 | % |   |   |   |   |

|                    |   | For      the Fiscal Quarters Ended January      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------|--------|----------------------------------------------------------|--------|--------|------------------------------------------------|--------|
|                    |   | 2010                                                     |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Effective      tax rate |   |                                                     | (56.4  | %)     |                                           |   | (55.6 | %) |   |   | (75.3 | %) |   |   | (144.7 | %) |

----

| Operating      Segment                  | Principal      Business                             |
|-----------------------------------------|-----------------------------------------------------|
| Sign      Making and Specialty Graphics | Gerber      Scientific Products ("GSP") and Spandex |
| Apparel      and Flexible Materials     | Gerber      Technology                              |
| Ophthalmic      Lens Processing         | Gerber      Coburn                                  |

|                         |   | For      the Fiscal Quarters Ended January 31, |   |
|------------------------------|--------|------------------------------------------------|--------|
|                         |   | 2010                                           |   |   | 2009 |   |
| In      thousands            |   | GSP                                            |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |
| Revenue                      |   | $                                              | 9,341  |   |   | $ | 50,267 |   |   | $ | 59,608 |   |   | $ | 11,938 |   |   | $ | 45,430 |   |   | $ | 57,368 |   |
| Operating      (loss) income |   | $                                              | (2,488 | ) |   | $ | 2,730 |   |   | $ | 242 |   |   | $ | 334 |   |   | $ | 704 |   |   | $ | 1,038 |   |

|                         |   | For      the Nine Months Ended January 31, |   |
|------------------------------|--------|--------------------------------------------|--------|
|                         |   | 2010                                       |   |   | 2009 |   |
| In      thousands            |   | GSP                                        |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |
| Revenue                      |   | $                                          | 33,603 |   |   | $ | 159,094 |   |   | $ | 192,697 |   |   | $ | 45,457 |   |   | $ | 177,122 |   |   | $ | 222,579 |   |
| Operating      (loss) income |   | $                                          | (4,950 | ) |   | $ | 9,255 |   |   | $ | 4,305 |   |   | $ | (881 | ) |   | $ | 6,832 |   |   | $ | 5,951 |   |

----

|                          |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands             |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Revenue                       |   | $                                                  | 40,095 |   |                                           | $      | 36,437 |   |   | $ | 112,249 |   |   | $ | 130,768 |   |
| Segment      operating income |   | $                                                  | 4,140  |   |                                           | $      | 2,778 |   |   | $ | 11,597 |   |   | $ | 11,373 |   |

----

|                                 |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|--------------------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands                    |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Revenue                              |   | $                                                  | 10,968 |   |                                           | $      | 12,386 |   |   | $ | 36,473 |   |   | $ | 43,562 |   |
| Segment      operating (loss) income |   | $                                                  | (318   | )      |                                           | $      | 737 |   |   | $ | 2,002 |   |   | $ | 2,625 |   |

|                    |   | For      the Fiscal Quarters EndedJanuary      31, |   |   | For      the Nine Months EndedJanuary      31, |   |
|-------------------------|--------|----------------------------------------------------|--------|--------|------------------------------------------------|--------|
| In      thousands       |   | 2010                                               |   |   | 2009                                           |   |   | 2010 |   |   | 2009 |   |
| Operating      expenses |   | $                                                  | 4,303  |   |                                           | $      | 4,336 |   |   | $ | 11,823 |   |   | $ | 12,632 |   |

----

|  In      thousands, except ratio amounts                  |   | January      31,2010 |    |   | April      30,2009 |   |
|----------------------------------------------------------------|--------|----------------------|---------|--------|--------------------|--------|
| Cash      and cash equivalents                                 |   | $                    | 7,921   |   |               | $      | 10,313 |   |
| Working      capital                                           |   | $                    | 77,267  |   |               | $      | 92,839 |   |
| Total      debt                                                |   | $                    | 45,000  |   |               | $      | 73,500 |   |
| Net      debt (total debt less cash and cash equivalents) |   | $                    | 37,079  |   |               | $      | 63,187 |   |
| Shareholders'      equity                                      |   | $                    | 163,642 |   |               | $      | 148,302 |   |
| Total      capital (net debt plus shareholders' equity)        |   | $                    | 200,721 |   |               | $      | 211,489 |   |
| Current      ratio                                             |   | 1.90:1               |    |   | 2.02:1             |   |
| Net      debt-to-total capital ratio                           |   |                 | 18.5    | %      |               |   | 29.9 | % |

----

|                                                        | For      the Nine Months Ended January 31, |   |
|-------------------------------------------------------------|--------------------------------------------|--------|
| In      thousands                                           |                                       | 2010   |   |   | 2009 |   |
| Cash      flows provided by operating activities            |                                       | $      | 19,478 |   |   | $ | 6,318 |   |
| Cash      flows provided by (used for) investing activities |                                       | $      | 5,299 |   |   | $ | (38,559 | ) |
| Cash      flows (used for) provided by financing activities |                                       | $      | (28,256 | )  |   | $ | 32,628 |   |

----

| Twelve      Month Period Ended    | Previous      Covenant | Amended      Covenant |
|-----------------------------------|------------------------|-----------------------|
| January      31, 2010             | Maximum      3.25:1    | Maximum      3.00:1   |
| April      30, 2010               | Maximum      3.25:1    | Maximum      3.00:1   |
| July      31, 2010 and thereafter | Maximum      3.00:1    | Maximum      3.00:1   |

| Twelve      Month Period Ended       | Previous      Covenant | Amended      Covenant |
|--------------------------------------|------------------------|-----------------------|
| January      31, 2010                | Minimum      2.25:1    | Minimum      1.50:1   |
| April      30, 2010                  | Minimum      2.75:1    | Minimum      2.25:1   |
| July      31, 2010                   | Minimum      3.00:1    | Minimum      2.50:1   |
| October      31, 2010 and thereafter | Minimum      3.00:1    | Minimum      3.00:1   |

----

| Covenant                                                | Requirement         | Actual      as of January 31, 2010 |
|---------------------------------------------------------|---------------------|------------------------------------|
| Total      Funded Debt to Consolidated EBITDA           | Maximum      3.00:1 | 2.36:1                             |
| Consolidated      EBIT to Consolidated Interest Expense | Minimum      1.50:1 | 2.66:1                             |
| Asset      Coverage Ratio                               | At      least 1.0:1 | 1.52:1                             |

ITEM 3.     QUANTITATIVE AND QUALITATIVEDISCLOSURES ABOUT MARKET RISK

ITEM 4.     CONTROLS ANDPROCEDURES

----

PART II -  OTHER INFORMATION

ITEM 1A.  RISK FACTORS

ITEM2.     UNREGISTERED SALES OF EQUITY SECURITIES AND USEOF PROCEEDS

| Period                                              |   | (a)TotalNumberof      Shares(or      Units)Purchased |   |   | (b)AveragePricePaid      perShare(or      Unit) |   | (c)Total      Number ofShares      (or Units)Purchased      as Partof      PubliclyAnnounced      Plansor      Programs | (d)MaximumNumber      (orApproximateDollar      Value)of      Shares (or Units)that      May Yet BePurchased      Under thePlans      or Program |
|-----------------------------------------------------|--------|------------------------------------------------------|--------|--------|-------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| November      1, 2009 – November 30, 2009     |   |                                                 | ---    |   |                                            |   | ---                                                                                                                     |                                                                                                                                             | Not      applicable | Not      applicable |
| December      1, 2009 – December 31, 2009 (1) |   |                                                 | 14,129 |   |                                            | $      | 5.04                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |
| January      1, 2010 – January 31, 2010 (1)   |   |                                                 | 2,072  |   |                                            |   | 4.94                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |
|                                                |   |                                                 | 16,201 |   |                                            | $      | 5.02                                                                                                                    |                                                                                                                                             | Not      applicable | Not      applicable |

----

ITEM 6.     EXHIBITS

| Exhibit      Number |   | Description |
|---------------------|--------|-------------|
|                |   |        |
|                | 10.1   |        | Third      Amendment to Credit Agreement, dated as of November 19, 2009, among Gerber      Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP      Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch      Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS      Citizens N.A. as lender and agent.  Filed    herewith. |
|                |   |        |   |
|                | 31.1   |        | Certification      of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|                |   |        |   |
|                | 31.2   |        | Certification      of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|                |   |        |   |
|                | 32     |        | Certification      of Chief Executive Officer and Chief Financial Officer pursuant to Rule      13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18      U.S.C. 1350, filed herewith. |

----

SIGNATURE

|               | GERBER      SCIENTIFIC, INC.                                                                                                                                                  |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| March      8, 2010 | By:                                                                                                                                                                           |                                                                                  /s/    Michael R.      Elia                  |
|               |  Michael R.      EliaExecutive      Vice President, Chief Financial Officer and Chief Accounting      Officer(Principal      Financial and  AccountingOfficer) |

----

Exhibit Index

| Exhibit      Number |   | Description |
|---------------------|--------|-------------|
|                |   |        |
|                | 10.1   |        | Third      Amendment to Credit Agreement, dated as of November 19, 2009, among Gerber      Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP      Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch      Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS      Citizens N.A. as lender and agent.  Filed    herewith. |
|                |   |        |   |
|                | 31.1   |        | Certification      of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|                |   |        |   |
|                | 31.2   |        | Certification      of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)      under the Securities Exchange Act of 1934, filed  herewith. |
|                |   |        |   |
|                | 32     |        | Certification      of Chief Executive Officer and Chief Financial Officer pursuant to Rule      13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18      U.S.C. 1350, filed herewith. |

----